News
Latest News
July 2026

2026 Bio Asia Taiwan

Share:

 


BIO Asia-Taiwan 2026 will officially take place on July 16, 2026, at the 4th floor of Taipei Nangang Exhibition Center, Hall 1.

Xantho Biotechnology will jointly exhibit and share a booth with the Development Center for Biotechnology (DCB) at Booth M434. We warmly welcome you to visit us at the exhibition.

Through this annual industry event, we look forward to continuing to share the results of our Phase I/IIa clinical trial for atopic dermatitis with biotechnology and pharmaceutical companies from Taiwan and around the world.

Looking ahead, in addition to advancing the Phase IIb clinical development, we plan to expand the development of GM-XANTHO® into a new indication for the rare disease pachyonychia congenita(PC), further broadening its therapeutic applications and commercial potential.

 

 

 

 

聲明:

本文章及網站中所發佈之相關資料含有預測性敘述,此類敘述是基於現況的預測和評估。這些預測性敘述將受不確定性、風險與其他非本公司所能掌控等因素影響。

惟仍存有許多因素可能使事件的發展或其實際結果與預測性敘述有重大差異。本公司不負任何更新或修訂之責任。

Related Information

Latest News: Xantho Biotechnology Participates in 2025 Bio-Europe Conference, Actively Expanding International Licensing and Collaboration for GM-XANTHO
MORE

Latest News: Xantho Biotechnology Participates in 2025 Bio-Europe Conference, Actively Expanding International Licensing and Collaboration for GM-XANTHO

Latest News: Xantho Biotechnology Participates in 2025 Bio-Europe Conference, Actively Expanding International Licensing and Collaboration for GM-XANTHO

December 2025
XANTHO Bio Seeks International Licensing, Initiates Phase 2b Clinical Trial
MORE

XANTHO Bio Seeks International Licensing, Initiates Phase 2b Clinical Trial

XANTHO Bio Seeks International Licensing, Initiates Phase 2b Clinical Trial

July 2025
Congrats! Australian Patent for GM-XAN003 Granted – A New Breakthrough in Psoriasis Treatment!
MORE

Congrats! Australian Patent for GM-XAN003 Granted – A New Breakthrough in Psoriasis Treatment!

Congrats! Australian Patent for GM-XAN003 Granted – A New Breakthrough in Psoriasis Treatment!

April 2025
Congrats! Tawain Patent for GM-XAN003 Granted- A New Breakthrough in Psoriasis Treatment
MORE

Congrats! Tawain Patent for GM-XAN003 Granted- A New Breakthrough in Psoriasis Treatment

Congrats! Tawain Patent for GM-XAN003 Granted- A New Breakthrough in Psoriasis Treatment

February 2025

Thank you for your visit!

To provide you with better service, this website will place and access our cookies on your computer. If you do not wish to accept the writing of cookies, you can set the privacy level to high in the features of your browser to refuse the writing of cookies. However, this may result in certain functions of the website not working properly.

Manage Cookies

Privacy preferences

Thank you for your visit!

To provide you with better service, this website will place and access our cookies on your computer. If you do not wish to accept the writing of cookies, you can set the privacy level to high in the features of your browser to refuse the writing of cookies. However, this may result in certain functions of the website not working properly.

Privacy Policy

Manage preferences

Necessary cookie

Always on

The website relies on these cookies, and you cannot disable them in the system. These cookies are typically set based on your actions (i.e., service requests), such as setting privacy preferences, logging in, or filling out forms. You can configure your browser to block or prompt you about these cookies, but this may result in certain website functions not working properly.